NM_015702.3(MMADHC):c.757G>A (p.Gly253Arg) AND not specified

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: May 3, 2022
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV002266486.1

Allele description [Variation Report for NM_015702.3(MMADHC):c.757G>A (p.Gly253Arg)]

NM_015702.3(MMADHC):c.757G>A (p.Gly253Arg)

Gene:

MMADHC:metabolism of cobalamin associated D [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

2q23.2

Genomic location:

Preferred name:

NM_015702.3(MMADHC):c.757G>A (p.Gly253Arg)

HGVS:

NC_000002.12:g.149570108C>T
NG_009189.1:g.22709G>A
NM_015702.3:c.757G>AMANE SELECT
NP_056517.1:p.Gly253Arg
NC_000002.11:g.150426622C>T
NM_015702.2:c.757G>A

Protein change:

G253R

Links:

dbSNP: rs766533747

NCBI 1000 Genomes Browser:

rs766533747

Molecular consequence:

NM_015702.3:c.757G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:: AllHighlyPenetrant
Identifiers:: MedGen: CN169374

Recent activity

Clear Turn Off Turn On

PREDICTED: Oncorhynchus gorbuscha aspartyl/asparaginyl beta-hydroxylase-like (LO...
PREDICTED: Oncorhynchus gorbuscha aspartyl/asparaginyl beta-hydroxylase-like (LOC124041947), transcript variant X6, misc_RNA
gi|2186820019|ref|XR_006840015.1|

Nucleotide

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV002547484	Women's Health and Genetics/Laboratory Corporation of America, LabCorp	criteria provided, single submitter (LabCorp Variant Classification Summary - May 2015)	Uncertain significance (May 3, 2022)	germline	clinical testing	Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV002547484

Women's Health and Genetics/Laboratory Corporation of America, LabCorp

criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)

Uncertain significance
(May 3, 2022)

germline

clinical testing

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV002547484.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Dec 24, 2023

ClinVar

Relating variation to medicine